We are live on ! Find out more
IVF

INVO Fertility Inc

5 hedge funds and large institutions have $153K invested in INVO Fertility Inc in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0% more funds holding

Funds holding: 55 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0.01% less ownership

Funds ownership: 0.01%0% (-0.01%)

39% less capital invested

Capital invested by funds: $251K → $153K (-$97.8K)

Holders
5
Holders Change
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

IVF Hedge Fund Activity: Q4 2023 in Review

5 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in INVO Fertility Inc (IVF) for Q4 2023, worth a combined $153K — down 39% from $251K a quarter earlier.

Fund positioning in IVF was balanced in Q4 2023: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $70.9K. The largest seller was Sabby Management, cutting an estimated $274K.

  • 5 institutional investors held INVO Fertility Inc (IVF) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $153K of INVO Fertility Inc stock for Q4 2023, down 39% quarter-over-quarter.
  • 2 funds opened new INVO Fertility Inc positions in Q4 2023 and 2 closed out, a net change of 0 holders.
  • The largest INVO Fertility Inc buyer in Q4 2023 was Vanguard Group, an estimated $70.9K added.
  • The largest INVO Fertility Inc seller in Q4 2023 was Sabby Management, an estimated $274K sold.

Based on aggregated 13F filings for Q4 2023.